Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
An animal model is the non-human species which is used generally in medical research because it can simulate aspects of a disease which are found in humans. Animal models are used for obtaining information about the diseases and their preventions, diagnosis and treatment. Scientists employs animal to gain information related to health problems which affects humans as well as animals and to ensure the safety of new medical treatments. Animals are needed for development of drugs and medical procedures for treatment of diseases.
The Europe humanized mouse model market is observing rapid growth during forecast period 2019 - 2028. The animal models are employ for addressing different scientific questions from basic science to the development and assessment of novel vaccines or therapies. The dynamic factors such as surge in use of animal models in pre-clinical development is propelling growth of Europe humanized mouse models market. The increasing pipeline of pharmaceutical companies is boosting growth of Europe humanized mouse models market. However, growing opposition on animal testing by several organization is hindering the growth of Europe humanized mouse models market.
The exclusive COVID-19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the humanized mouse models market. In addition, complete analysis of changes on humanized mouse models expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on Europe economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The rising incidences of various diseases and viral infections such as COVID-19 increases the demand for humanized mouse models for research activity during COVID-19 period. The rising prevalence of infectious diseases is also boosting growth of humanized mouse models market during COVID-19 pandemics. The rising use of animal models for development of research activities is also boosting growth of humanized mouse models market during COVID-19 period.
The Europe humanized mouse models market is segmented into the type, application, end user and country.
Based on type, the Europe humanized mouse is segmented into the cell-based humanized mouse models and genetic humanized mouse models. In which genetic humanized mouse models are expected to dominate the market in 2020. The increasing use of genetic models for analysis of compounds, biological efficacy and safety testing is also boosting growth of humanized mouse models market. The rising investigational study for new drug development is also propelling growth of humanized mouse models market.
Based on application, the Europe humanized mouse models market is bifurcated into the immunology and infectious diseases, neuroscience, oncology, haematopoiesis, toxicology and other. In which neuroscience is also contributing to the growth of Europe humanized mouse models market. The rising need for understanding human diseases is propelling growth of Europe humanized mouse models market. In increasing study of neuroscientific parameters is also boosting growth of Europe humanized mouse models market.
Based on end user, the Europe humanized mouse models market is categorised into the pharmaceutical and biotechnology companies, contract research organizations and academic and research institution. In which academic and research institution is also contributing to the growth of market. The rising study on animal models in academic institutes is propelling growth of Europe humanized mouse models market. The growing number of academic and research institution is also refuelling growth of Europe humanized mouse models market.
The Europe humanized mouse models market is studied for key countries such as United Kingdom, Germany, France, Italy and Spain. In which United Kingdom is anticipated to dominate the market in 2020. The increasing healthcare infrastructure is propelling growth of the market. The growing research and development activities is also boosting growth of the market. The rising academic and research institutes is also refuelling growth of the market.
The major key players in humanized mouse models market are The Jackson Laboratory, Taconic Biosciences Inc., Harbour Biomed, Humurine Technologies Inc., Vitalstar Biotechnology Co. Ltd., Crown Bioscience Inc., Ingenious Targeting Laboratory, Axenis S.A.S., Trans Genic Inc. and Genoway S.A. among others.
January 2021: The Champion Oncology Inc., a well-known global oncology technology company which is transforming drug discovery and development by the data driven research strategies announced the expansion of its Lumin Bioinformatics SaaS program.
December 2020: The Perkin Elmer Inc., and Horizon Discovery Group plc announced the agreement on the terms of a recommended all-cash offer in Perkin Elmer will acquire Horizon.
January 2020: The Taconic Biosciences, a global leader in the development of drug discovery animal model has launched a new model generation facility in Leverkusen, Germany.
January 2020: The H.I.G. Capital announced that one of their affiliates has joined forces with the management team of Taconic Biosciences inc., for supporting company’s growth as the leading provider of research models and services to the pharmaceutical, biotechnology and contract research organizations.
The report analyses the humanized mouse models based on the type, application, end user and country. The various types of humanized mouse models covered in the report are genetic humanized mouse models and cell-based humanized mouse models. By Application, the market is segmented into the immunology and infectious diseases, neuroscience, oncology, haematopoiesis, toxicology and other. Based on end user, the market is segmented into the pharmaceutical and biotechnology companies, contract research organization and academic and research institutes. The report also analyses the impact of COVID-19 on the market and it found that the rising incidences of various diseases and viral infections such as COVID-19 increases the demand for humanized mouse models for research activity during COVID-19 period. The rising prevalence of infectious diseases is also boosting growth of humanized mouse models market during COVID-19 pandemics. The rising use of animal models for development of research activities is also boosting growth of humanized mouse models market during COVID-19 period. The report also analyses the major key players operating in the market.
Why to buy this report:
